Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

S001 - Gross and Microscopic Symposium

Friday, February 16; 9:00 AM - 5:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Review and interpret a broad variety of dermatological conditions through multiple clinical cases presented in a fast pace, with clinical, surgical, and dermatopathological correlations.
  • Recognize a wide variety of dermatological entities with direct applicability to patient care.
  • Increase your diagnostic and treatment skills.

Description

Two-full day symposium entails 192 presentations, which will cover the gamut of clinical dermatology, predicated on clinical/pathological correlation, with attention to new and interesting observations. Presentations will be grouped into several clinical categories allowing attenders to focus on particular conditions/entities. Each presentation will be five minutes long, including a clinical/pathological case, and review of the topic. As such, this symposium is lively and fast paced, hopefully "with something for everyone" in the audience. Presentations will be clinically germane and applicable to patient care. Symposium is open to all AAD members, non-members, residents, fellows, and medical students.

Disclosures

  • Alonso-Llamazares, Javier, MD: Celgene Corporation – SP(H); UCB – SP(H);
  • Friedman, Adam J., MD: Aclaris Therapeutics Inc. – I(Grants/Research Funding); Allergan, Inc. – Speaker/Faculty Education(H); Amgen – A(H), Speaker/Faculty Education(H); Bayer – SP(H); Biogen – A(H); Dermira – C(H); Eli Lilly and Company – C(H); Encore Dermatology, Inc. – C(H); Exeltis – C(H); Galderma USA – C(H); IntraDerm Pharmaceuticals – C(H); Janssen Biotech – SP(H), Speaker/Faculty Education(H); Johnson and Johnson Consumer Products Company – C(H); La Roche-Posay Laboratorie Pharmaceutique – A(H); Medscape – Speaker/Faculty Education(H); Menlo Therapeutics – A(H); Novartis – A(H); Oculus innovative Sciences, Inc. – C(H); Orlando Dermatology Aesthetic & Clinical (ODAC) – SP(H); Pfizer Inc. – C(H); Promius Pharma, LLC – A(H), SP(H); Regeneron – Speaker/Faculty Education(H); Sanova Works – C(H); Valeant Pharmaceuticals International – I(Grants/Research Funding); Valeant Pharmaceuticals North America LLC – A(H);
  • Gasbarre, Christopher C., DO: no financial relationships exist with commercial interests.
  • Gomez, Minerva, MD: no financial relationships exist with commercial interests.
  • Han, George, MD, PhD: Celgene – I(Grants/Research Funding); Eli Lilly and Company – I(Grants/Research Funding); Janssen Pharmaceuticals, Inc – A(H), I(Grants/Research Funding); MC2 Therapeutics – I(Grants/Research Funding); Pfizer Inc. – SP(NC); Regeneron Pharmaceuticals, Inc. – A(H), SP(H); Sanofi – A(H), SP(H); Sun Pharmaceutical Industries Ltd. – SP(H);
  • Martinez, Jose Dario, MD: no financial relationships exist with commercial interests.
  • Mesinkovska, Natasha Atanaskova, MD, PhD: BiologicsMD, Inc. – C(H);
  • Tarbox, Michelle B., MD: no financial relationships exist with commercial interests.
Schedule
Friday, February 16
9:00 AM
All faculty / Gross & Microscopy Symposium
9:00 AM
All faculty / Gross & Microscopy Symposium
Event Details
  • Date
    Friday, February 16
  • Time
    9:00 AM - 5:00 PM
  • Location
    Room 9
  • CME Credits
    16.00
  • Type
Directors/Co-Directors
Speakers
  • Adam J. Friedman, MD, FAAD
  • Christopher C. Gasbarre, DO, FAAD
  • George Han, MD, PhD, FAAD
  • Javier Alonso-Llamazares, MD, FAAD
  • Michelle B. Tarbox, MD, FAAD
  • Minerva Gomez, MD